Evidence map›Paper›PMID 30906849›Full record

ArticleRegenerative engineering and translational medicine2018

Surfactant Copolymer Annealing of Chemically Permeabilized Cell Membranes.

Hongfeng Chen, Colin McFaul, Igor Titushkin, Michael Cho, Raphael Lee

Abstract read
In one paragraph

Article in Regenerative engineering and translational medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hongfeng ChenDepartment of Surgery, University of Chicago, Chicago, IL, USA, 60637.
Colin McFaulDepartment of Surgery, University of Chicago, Chicago, IL, USA, 60637.
Igor TitushkinDepartment of Surgery, University of Illinois at Chicago, Chicago IL, USA, 60605.
Michael ChoDepartment of Surgery, University of Illinois at Chicago, Chicago IL, USA, 60605.
Raphael LeeDepartment of Surgery, University of Chicago, Chicago, IL, USA, 60637.

Funding

Membrane Sealing:Biopolymers for Tissue ElectroporationR01GM064757 · NIGMS · UNIVERSITY OF CHICAGO · PI LEE, RAPHAEL CARL · 2002 to 2010
$2.6M
Trauma Molecular Pathogenesis and Regeneration Training GrantT32GM099697 · NIGMS · UNIVERSITY OF CHICAGO · PI LEE, RAPHAEL CARL · 2012 to 2016
$536k
NIGMS NIH HHS R01 GM064757NIGMS NIH HHS T32 GM099697
6 · The paper itself

Abstract

Structural breakdown of the cell membrane is a primary mediator in trauma induced tissue necrosis. When membrane disruption exceeds intrinsic membrane sealing processes, biocompatible multi-block amphiphilic copolymer surfactants such as Poloxamer 188 (P188) have been found to be effective in catalyze or augment sealing. Although in living cells copolymer induced sealing of membrane defects has been detected by changes in membrane transport properties, it has not been directly imaged. In this project we used Atomic force microscopy (AFM) to directly image saponin permeabilized and poloxamer sealed plasma membranes of monolayer cultured MDCK and 3T3 fibroblasts. AFM image analysis resulted in the density and diameter ranges for membrane indentations per 5×5 μm area. For control, saponin lysed, and P188 treatment of saponin lysed membranes, the supra-threshold indentation density was 3.6 ± 2.8, 13.8 ± 6.7, and 4.9 ± 3.3/cell, respectively. These results indicated that P188 catalyzed reduction in size of AFM indentations which correlated with increase cell survival. This evidence confirm that biocompatible surfactant P188 augment natural cell membrane sealing capability when intrinsic processes are incapable alone.

Identifiers

PMID30906849
PMCPMC6426139

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.